FFA
ONC icon

Farther Finance Advisors’s BeOne Medicines Ltd ONC Stock Holding History

Farther Finance Advisors’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$96.6K Sell
264
-3
-1% -$1.03K ﹤0.01% 2890
2026
Q2 		$76.2K Buy
267
+45
+20% +$13.3K ﹤0.01% 2922
2026
Q1 		$68.5K Buy
222
+4
+2% +$1.29K ﹤0.01% 2773
2025
Q4 		$66.2K Buy
218
+39
+22% +$12.8K ﹤0.01% 2625
2025
Q3 		$61K Buy
179
+19
+12% +$5.77K ﹤0.01% 2332
2025
Q2 		$38.7K Buy
160
+64
+67% +$15.7K ﹤0.01% 2260
2025
Q1 		$26K Buy
96
+12
+14% +$2.81K ﹤0.01% 2253
2024
Q4 		$15.5K Buy
84
+69
+460% +$14.1K ﹤0.01% 2193
2024
Q3 		$3.37K Buy
15
+4
+36% +$720 ﹤0.01% 2803
2024
Q2 		$1.59K Sell
11
-32
-74% -$4.93K ﹤0.01% 2882
2024
Q1 		$6.85K Sell
43
-2
-4% -$322 ﹤0.01% 1927
2023
Q4 		$8.12K Buy
45
+21
+88% +$3.8K ﹤0.01% 1711
2023
Q3 		$4.32K Buy
24
+5
+26% +$989 ﹤0.01% 1562
2023
Q2 		$3.39K Hold
19
– – ﹤0.01% 1567
2023
Q1 		$4.09K Buy
+19
New +$4.56K ﹤0.01% 1397

Other funds holding ONC

HIA
Harbor Investment Advisory Lutherville, Maryland $1.47B AUM 24.2% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Farther Finance Advisors's ONC Position: Q3 2026 in Review

Farther Finance Advisors reduced its BeOne Medicines Ltd (ONC) stake by 1.1% in Q3 2026, selling an estimated $1.03K and leaving 264 shares worth $96.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2890.

Farther Finance Advisors first reported a position in ONC in Q1 2023 and has held it in 15 quarters since. 6 funds tracked by Wall St. Rank hold ONC as of Q3 2026.

  • Farther Finance Advisors held 264 shares of BeOne Medicines Ltd worth $96.6K as of Q3 2026.
  • Farther Finance Advisors sold 3 BeOne Medicines Ltd shares in Q3 2026, an estimated $1.03K.
  • BeOne Medicines Ltd made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #2890 holding.
  • Farther Finance Advisors first reported a position in BeOne Medicines Ltd in Q1 2023 and has held it in 15 quarters since.
  • 6 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.